Skip to main content
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 4/2011

01.04.2011 | Reports of Original Investigations

Geographic differences in the target-controlled infusion estimated concentration of propofol: bispectral index response curves

verfasst von: Ashraf A. Dahaba, MD, PhD, Taidi Zhong, MD, Hui Shun Lu, MD, Helmar Bornemann, MD, Markus Liebmann, MD, Georg Wilfinger, MD, Gilbert Reibnegger, PhD, Helfried Metzler, MD

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Variability in drug responses could result from both genetic and environmental factors. Thus, drug effect could depend on geographic location, although regional variation is not generally acknowledged as a basis for stratification. There is evidence that the pharmacokinetic set developed in a European population for the target-controlled infusion (TCI) of propofol does not apply in Chinese patients; however, we are not aware of previous studies comparing the estimated concentration-bispectral index (BIS) response of Caucasian patients in Europe with that of Chinese patients in China.

Methods

The DiprifusorTM TCI pump, incorporating the pharmacokinetic model proposed by Marsh et al., was applied to 30 Caucasian patients in Austria and 30 Chinese patients in China. The estimated plasma concentration (Cp) of propofol for the two groups was set at 1 μg·mL−1 and increased by 1 μg·mL−1 every minute to gradually reach 5 μg·mL−1 after 5 min. The BIS values were fitted against the estimated Cp and the predicted effect-site concentration (Ce) in a sigmoid Emax model.

Results

The sigmoid Emax curves were shifted significantly to the left in the Chinese group compared with the Austrian group. After 5 min, the BIS value in the Chinese group was lower than in the Austrian group (mean ± standard deviation [SD], 47.2 ± 3.6 vs 63.6 ± 5.4, respectively; P = 0.0006). The estimated Cp at loss of consciousness (LOC), predicted Ce at LOC, and time to LOC, were lower in the Chinese group than in the Austrian group (3.3 ± 0.8 μg·mL−1, 1.6 ± 0.4 μg·mL−1, 2.8 ± 0.6 min, respectively, vs 4.6 ± 2.8 μg·mL−1, 2.4 ± 1.5 μg·mL−1, 3.9 ± 0.5 min, respectively; P < 0.0001).

Conclusion

When propofol is given using the same TCI protocol, Chinese patients in China lost consciousness faster and at a lower estimated plasma concentration than Caucasians in Austria. Larger studies are needed to map geographically appropriate TCI infusion models.
Literatur
1.
Zurück zum Zitat Ortolani O, Conti A, Chan YK, Sie MY, Ong GS. Comparison of propofol consumption and recovery time in Caucasians from Italy, with Chinese, Malays and Indians from Malaysia. Anaesth Intensive Care 2004; 32: 250-5.PubMed Ortolani O, Conti A, Chan YK, Sie MY, Ong GS. Comparison of propofol consumption and recovery time in Caucasians from Italy, with Chinese, Malays and Indians from Malaysia. Anaesth Intensive Care 2004; 32: 250-5.PubMed
2.
Zurück zum Zitat Ortolani O, Conti A, Ngumi ZW, et al. Ethnic differences in propofol and fentanyl response: a comparison among Caucasians, Kenyan Africans and Brazilians. Eur J Anaesthesiol 2004; 21: 314-9.PubMed Ortolani O, Conti A, Ngumi ZW, et al. Ethnic differences in propofol and fentanyl response: a comparison among Caucasians, Kenyan Africans and Brazilians. Eur J Anaesthesiol 2004; 21: 314-9.PubMed
3.
Zurück zum Zitat Rampil IJ. A primer for EEG signal processing in anesthesia. Anesthesiology 1998; 89: 980-1002.PubMedCrossRef Rampil IJ. A primer for EEG signal processing in anesthesia. Anesthesiology 1998; 89: 980-1002.PubMedCrossRef
4.
Zurück zum Zitat White M, Schenkels MJ, Engbers FH, et al. Effect-site modelling of propofol using auditory evoked potentials. Br J Anaesth 1999; 82: 333-9.PubMed White M, Schenkels MJ, Engbers FH, et al. Effect-site modelling of propofol using auditory evoked potentials. Br J Anaesth 1999; 82: 333-9.PubMed
5.
Zurück zum Zitat Xu Z, Liu F, Yue Y, et al. C50 for propofol-remifentanil target-controlled infusion and bispectral index at loss of consciousness and response to painful stimulus in Chinese patients: a multicenter clinical trial. Anesth Analg 2009; 108: 478-83.PubMedCrossRef Xu Z, Liu F, Yue Y, et al. C50 for propofol-remifentanil target-controlled infusion and bispectral index at loss of consciousness and response to painful stimulus in Chinese patients: a multicenter clinical trial. Anesth Analg 2009; 108: 478-83.PubMedCrossRef
6.
Zurück zum Zitat Zhang MZ, Yu Q, Huang YL, Wang SJ, Wang XR. A comparison between bispectral index analysis and auditory-evoked potentials for monitoring the time to peak effect to calculate the plasma effect site equilibration rate constant of propofol. Eur J Anaesthesiol 2007; 24: 876-81.PubMedCrossRef Zhang MZ, Yu Q, Huang YL, Wang SJ, Wang XR. A comparison between bispectral index analysis and auditory-evoked potentials for monitoring the time to peak effect to calculate the plasma effect site equilibration rate constant of propofol. Eur J Anaesthesiol 2007; 24: 876-81.PubMedCrossRef
7.
Zurück zum Zitat Milne SE, Troy A, Irwin MG, Kenny GN. Relationship between bispectral index, auditory evoked potential index and effect-site EC50 for propofol at two clinical end-points. Br J Anaesth 2003; 90: 127-31.PubMedCrossRef Milne SE, Troy A, Irwin MG, Kenny GN. Relationship between bispectral index, auditory evoked potential index and effect-site EC50 for propofol at two clinical end-points. Br J Anaesth 2003; 90: 127-31.PubMedCrossRef
8.
Zurück zum Zitat Irwin MG, Hui TW, Milne SE, Kenny GN. Propofol effective concentration 50 and its relationship to bispectral index. Anaesthesia 2002; 57: 242-8.PubMedCrossRef Irwin MG, Hui TW, Milne SE, Kenny GN. Propofol effective concentration 50 and its relationship to bispectral index. Anaesthesia 2002; 57: 242-8.PubMedCrossRef
9.
Zurück zum Zitat Marsh B, White M, Morton N, Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67: 41-8.PubMedCrossRef Marsh B, White M, Morton N, Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67: 41-8.PubMedCrossRef
10.
Zurück zum Zitat Li YH, Xu JH, Yang JJ, Tian J, Xu JG. Predictive performance of ‘Diprifusor’ TCI system in patients during upper abdominal surgery under propofol/fentanyl anesthesia. J Zhejiang Univ Sci B 2005; 6: 43-8.PubMedCrossRef Li YH, Xu JH, Yang JJ, Tian J, Xu JG. Predictive performance of ‘Diprifusor’ TCI system in patients during upper abdominal surgery under propofol/fentanyl anesthesia. J Zhejiang Univ Sci B 2005; 6: 43-8.PubMedCrossRef
11.
Zurück zum Zitat Coetzee JF, Glen JB, Wium CA, Boshoff L. Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets. Anesthesiology 1995; 82: 1328-45.PubMedCrossRef Coetzee JF, Glen JB, Wium CA, Boshoff L. Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets. Anesthesiology 1995; 82: 1328-45.PubMedCrossRef
12.
Zurück zum Zitat Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-4.PubMedCrossRef Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-4.PubMedCrossRef
13.
Zurück zum Zitat Minto CF, Schnider TW, Short TG, Gregg KM, Gentilini A, Shafer SL. Response surface model for anesthetic drug interactions. Anesthesiology 2000; 92: 1603-16.PubMedCrossRef Minto CF, Schnider TW, Short TG, Gregg KM, Gentilini A, Shafer SL. Response surface model for anesthetic drug interactions. Anesthesiology 2000; 92: 1603-16.PubMedCrossRef
14.
Zurück zum Zitat Dahaba AA, Oettl K, von Klobucar F, Reibnegger G, List WF. End stage renal failure reduces central clearance and prolongs the elimination half life of remifentanil. Can J Anesth 2002; 49: 369-74.PubMedCrossRef Dahaba AA, Oettl K, von Klobucar F, Reibnegger G, List WF. End stage renal failure reduces central clearance and prolongs the elimination half life of remifentanil. Can J Anesth 2002; 49: 369-74.PubMedCrossRef
15.
Zurück zum Zitat Dahaba AA, Perelman SI, Moskowitz DM, et al. Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosage. Anesthesiology 2006; 104: 950-3.PubMedCrossRef Dahaba AA, Perelman SI, Moskowitz DM, et al. Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosage. Anesthesiology 2006; 104: 950-3.PubMedCrossRef
16.
Zurück zum Zitat Benet LZ, Hoener BA. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 2002; 71: 115-21.PubMedCrossRef Benet LZ, Hoener BA. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 2002; 71: 115-21.PubMedCrossRef
17.
Zurück zum Zitat Rolan PE. Plasma protein binding displacement interactions -why are they still regarded as clinically important? Br J Clin Pharmacol 1994; 37: 125-8.PubMed Rolan PE. Plasma protein binding displacement interactions -why are they still regarded as clinically important? Br J Clin Pharmacol 1994; 37: 125-8.PubMed
18.
Zurück zum Zitat MacKichan JJ. Protein binding drug displacement interactions fact or fiction? Clin Pharmacokinet 1989; 16: 65-73.PubMedCrossRef MacKichan JJ. Protein binding drug displacement interactions fact or fiction? Clin Pharmacokinet 1989; 16: 65-73.PubMedCrossRef
19.
Zurück zum Zitat Hiraoka H, Yamamoto K, Okano N, Morita T, Goto F, Horiuchi R. Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding. Clin Pharmacol Ther 2004; 75: 324-30.PubMedCrossRef Hiraoka H, Yamamoto K, Okano N, Morita T, Goto F, Horiuchi R. Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding. Clin Pharmacol Ther 2004; 75: 324-30.PubMedCrossRef
20.
Zurück zum Zitat Mazoit JX, Samii K. Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics. Br J Clin Pharmacol 1999; 47: 35-42.PubMedCrossRef Mazoit JX, Samii K. Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics. Br J Clin Pharmacol 1999; 47: 35-42.PubMedCrossRef
21.
Zurück zum Zitat Takizawa E, Hiraoka H, Takizawa D, Goto F. Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass. Br J Anaesth 2006; 96: 179-85.PubMedCrossRef Takizawa E, Hiraoka H, Takizawa D, Goto F. Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass. Br J Anaesth 2006; 96: 179-85.PubMedCrossRef
22.
Zurück zum Zitat Zhou HH, Adedoyin A, Wilkinson GR. Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clin Pharmacol Ther 1990; 48: 10-7.PubMedCrossRef Zhou HH, Adedoyin A, Wilkinson GR. Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clin Pharmacol Ther 1990; 48: 10-7.PubMedCrossRef
23.
Zurück zum Zitat Dahaba AA, von Klobucar F, Rehak PH, List WF. Total intravenous anesthesia with remifentanil, propofol and cisatracurium in end stage renal failure. Can J Anesth 1999; 46: 696-700.PubMedCrossRef Dahaba AA, von Klobucar F, Rehak PH, List WF. Total intravenous anesthesia with remifentanil, propofol and cisatracurium in end stage renal failure. Can J Anesth 1999; 46: 696-700.PubMedCrossRef
24.
Zurück zum Zitat Absalom AR, Mani V, De Smet T, Struys MM. Pharmacokinetic models for propofol—defining and illuminating the devil in the detail. Br J Anaesth 2009; 103: 26-37.PubMedCrossRef Absalom AR, Mani V, De Smet T, Struys MM. Pharmacokinetic models for propofol—defining and illuminating the devil in the detail. Br J Anaesth 2009; 103: 26-37.PubMedCrossRef
25.
Zurück zum Zitat Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88: 1170-82.PubMedCrossRef Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88: 1170-82.PubMedCrossRef
Metadaten
Titel
Geographic differences in the target-controlled infusion estimated concentration of propofol: bispectral index response curves
verfasst von
Ashraf A. Dahaba, MD, PhD
Taidi Zhong, MD
Hui Shun Lu, MD
Helmar Bornemann, MD
Markus Liebmann, MD
Georg Wilfinger, MD
Gilbert Reibnegger, PhD
Helfried Metzler, MD
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 4/2011
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-011-9453-2

Weitere Artikel der Ausgabe 4/2011

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 4/2011 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.